FPM Journal Club with guest host Dr Martin Lunnon

For the vast majority of his professional career Martin has worked in the Pharmaceutical Industry and for the most of this in early phase clinical drug development; he is a clinical pharmacologist and has been involved in the development of over 30 new molecular entities, including biological products, but also including some later phase work, in a variety of therapeutic areas (cardiovascular, central nervous and more recently musculoskeletal).  Martin has worked for British, American, Swiss, Japanese, French and Norwegian­­­­­­ companies. The most recent position in ‘Big Pharma’ was with Sanofi R&D in Paris, which included involvement in a project for rare diseases. Following 7 years in France and return to England, Martin was appointed as visiting Senior Lecturer at King’s College London and taught on MSc courses in the Institute of Pharmaceutical Sciences until just before the COVID pandemic.

In addition he has acted as a consultant to 2 small pharmaceutical companies developing drugs for rare neurological diseases. Martin has been involved with Committee work for a good part of his career: the Society of Pharmaceutical Medicine (1987 to 2010, finishing as Chairman), where he was the Convenor of a Working Party on Pharmacogenetics which reported at the Royal Institute in 2000 and the British Pharmacological Society (BPS), member for over 30 years and served on the Committee of the Clinical Section of BPS and sometime reviewer for the British Journal of Clinical Pharmacology.